StockData
Nasus Pharma Ltd logo

Nasus Pharma Ltd (NSRX) stock

NSRXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 25, 2026Score 6/30
$2.55−0.15 (-5.56%)

Close on Nov 19, 2026Market cap $22.99MP/E –Yield –

Nasus Pharma free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -$4.93M.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$4.93M–

More Nasus Pharma figures

See a number that looks wrong?